about
Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.Multiple sclerosis in the very young: a case report and review of the literature.Cognitive changes in multiple sclerosis.Cortical pathology and cognitive impairment in multiple sclerosis.Disease progression in pediatric multiple sclerosis: disparities between physical and neurocognitive outcomes.Cognitive dysfunction in pediatric multiple sclerosis.A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosusLongitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.Therapeutic strategies in childhood multiple sclerosisNeurocognitive sequelae in African American and Caucasian children with multiple sclerosis.Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.Neuropsychiatric manifestations of multiple sclerosis.Disease-modifying therapy of pediatric multiple sclerosis.Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosisManagement of multiple sclerosis in adolescents - current treatment options and related adherence issues.Treatment of multiple sclerosis in children and adolescents.Cognitive impairment in pediatric multiple sclerosis.Therapies for multiple sclerosis: considerations in the pediatric patient.Management of children with multiple sclerosis.The management of pediatric multiple sclerosis.Neuropsychological correlates of multiple sclerosis across the lifespan.Physical activity and pediatric multiple sclerosis: Developing a research agenda.Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study.Can new chemical therapies improve the management of multiple sclerosis in children?Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?Neuropsychological outcomes of pediatric demyelinating diseases: a review.Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study.Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.Psychiatric comorbidity in pediatric patients with demyelinating disorders.Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.Age of onset as a moderator of cognitive decline in pediatric-onset multiple sclerosis.The management of multiple sclerosis in children: a European view.Intellectual ability and executive function in pediatric moyamoya vasculopathy.Fatigue and depression in children with demyelinating disorders.Multiple sclerosis in childhood: clinical and radiological features.Memory performance and normalized regional brain volumes in patients with pediatric-onset multiple sclerosis.Pediatric-Onset Multiple Sclerosis: A Single Center Study.A feasibility study of working memory training for individuals with paediatric-onset multiple sclerosis.
P2860
Q30354658-6F490DBD-D6B9-4295-91EE-491CEDE04A07Q31037769-5762A30F-0502-4E69-9400-CD5771FCDDE4Q33377548-D94C69E5-15F0-42E9-B9AB-EE3F96AAA6A3Q33837296-DCEF6F81-F413-4A2F-B937-8137A77783CBQ33837301-11C6F50A-A3C3-4671-AED5-747159BAA117Q33968709-98A99D98-A0B0-483C-A94B-3496E3B25BFDQ34114987-7F5BEC5F-19BB-4ECC-A6CE-0B25E45194E0Q34315953-AFB9C720-4C44-4DAA-9720-6B0F89E8A96BQ34409508-A8039A2A-5542-4665-93F6-BC6ED9580FDBQ36064719-A228F8BE-8E9F-4BE4-8C32-E9F60D2C5280Q36413401-FB5B783A-53B4-4E96-9189-6E2D343CA3B4Q36474339-DB7C4368-C10B-474E-8133-429B10894919Q36568645-7EA93B92-7375-4770-AC23-99F5002992BFQ36839814-91DCB02E-D971-441E-B1B8-8889416D0AA1Q37047770-72D93A42-A462-4E49-BAAF-7B7182AC8CC4Q37481523-F7EFFB7A-B655-4F17-8E3B-A90D33B7F52CQ37562003-694068E0-89BC-4FFE-A61A-8673148DF5DEQ37693918-86DE00E1-230D-489C-8028-4F9CD25241F4Q37799568-9D3896E8-C642-4A26-A484-ABAFD4A2C8DAQ37827690-51246AC7-85E8-47DC-9273-E3DDC217C21EQ38002113-FF7501C1-CD86-4341-AE97-C03539DDE782Q38036853-F100796F-A93D-4483-B7A0-A3583F6C1B0FQ38545084-BBD0E657-4034-48FA-8AAE-E9CC0D2F0D39Q38602040-8038C41A-0065-48F9-A1E1-E1E5E2810B14Q38728145-AB22F356-EA7D-42B1-B82E-1AA85ED0D25FQ39024427-9C2B7429-501E-49E4-A83B-21E5DE0D59E7Q39191862-50B6A1B7-CCE8-48DB-83D8-B9A7C7B2E59EQ39388520-AC588CE3-FB10-4E78-9F68-7A0C431E4E45Q40143991-30AF4C3B-9E08-4BDE-A133-D948D265AF67Q40871036-1945030C-3099-44C3-8B5D-415831C44877Q43769945-9DEDFFC3-0B53-448D-AB54-8CAC184F802FQ43802943-4FF9FA9D-76F5-47AE-B952-66EEBA26EAB8Q44098570-2C1FFD87-4EE4-431F-803C-F4DC71DF35B3Q45108726-6F4AC4BB-7F9D-4A00-B67D-70B0538BFAF4Q45804054-58128EAD-0B58-4415-9566-57781CC7EFE9Q46182973-C29C7F85-B588-447E-9EEC-612043A27F82Q46305250-9DBE2DE5-9F8D-44CE-9CA0-0BD5B61D4C64Q46581029-68C2BC4D-E797-4B2D-BD90-ED4971318B5DQ47301788-E4F0E44E-BDCA-4992-9896-5917132EE506Q47619693-51C8E794-D0EB-4F86-80E2-2F8283901E3B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The cognitive burden of multiple sclerosis in children.
@ast
The cognitive burden of multiple sclerosis in children.
@en
type
label
The cognitive burden of multiple sclerosis in children.
@ast
The cognitive burden of multiple sclerosis in children.
@en
prefLabel
The cognitive burden of multiple sclerosis in children.
@ast
The cognitive burden of multiple sclerosis in children.
@en
P1433
P1476
The cognitive burden of multiple sclerosis in children.
@en
P2093
Brenda L Banwell
Peter E Anderson
P304
P356
10.1212/01.WNL.0000152896.35341.51
P407
P577
2005-03-01T00:00:00Z